Radioimmunoscintigraphy for prostate cancer.
D054598:Blue Cross Blue Shield Insurance Plans; D017277:Drug Approval; D006801:Humans; D007205:Indium Radioisotopes; D008297:Male; D017064:Process Assessment, Health Care; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging*; D016719:Radioimmunodetection / Q000295:instrumentation / Q000379:methods; D012008:Recurrence; D012680:Sensitivity and Specificity; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration
D007205:Indium Radioisotopes